Biomica Raises $20 Million in a Financing Round to Advance its Pipeline of Microbiome-based Therapeutics

 Biomica Raises $20 Million in a Financing Round to Advance its Pipeline of Microbiome-based Therapeutics

Funding round led by Shanghai Healthcare Capital 
REHOVOT, Israel, Dec. 21, 2022 /PRNewswire/ — Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based ther…